A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Chinese Adults With Chronic Coronary Syndrome
Conditions
Chronic Coronary Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Anzhen Hospital, Beijing, China
Study leads
Clinical Trials
Study Director
Viatris Innovation GmbH